Biotech’s 2019 “Plot Twist”
After a rough end to 2018, with massive fund outflows in the fourth quarter, biotech’s condition has been improving in 2019 – and these two… Read More »Biotech’s 2019 “Plot Twist”
Fourth Quarter
After a rough end to 2018, with massive fund outflows in the fourth quarter, biotech’s condition has been improving in 2019 – and these two… Read More »Biotech’s 2019 “Plot Twist”